Anyone looking at $BIAF float is under 5M and the volume now is over 110M, they just posted good news

I’ve been watching BIAF for a bit now, and I honestly think this one is starting to get interesting.

The stock has been absolutely destroyed, so I’m not going to pretend this is some safe, easy trade. It’s a microcap, there are obvious risks, and dilution is always something investors need to keep in mind.

That said, I think the market might be overlooking what’s actually happening with the business.

What caught my attention is the growth they’ve been reporting with CyPath Lung. Test volume was up 146% year-over-year in Q1, and then they reported more than 200% year-over-year growth in Q2. For a company at this stage, that’s the kind of trend I want to see. The product actually appears to be gaining traction.

And that’s really what makes BIAF interesting to me right now.

The stock price tells you that nobody cares. Sentiment is terrible. But underneath that, the company has been reporting growing adoption, record sales months, and recently announced a partnership with Pictor to work on potential diagnostic opportunities involving asthma and COPD.

Could this still go lower? Absolutely.

Could they need to raise more money? Also possible.

But that’s already part of why I find the setup interesting. When a stock gets beaten down this badly, expectations become incredibly low. It doesn’t take perfection to surprise the market anymore. The company just needs to continue showing that CyPath Lung adoption is growing and that they can eventually turn that growth into meaningful revenue.

That’s obviously the big question.

For me, BIAF isn’t a stock I’m looking at because I think it suddenly becomes a $10 billion company overnight. I’m looking at it because the current valuation, the growth in test volume, and the disconnect between the stock price and the commercial progress make the risk/reward interesting.

This is definitely a speculative play, and everyone should do their own research.

But personally, I think BIAF is one of those names where things could get very interesting if they continue executing.

Sometimes the best opportunities are the companies nobody wants to talk about anymore.

**BIAF is on my radar.**

*Not financial advice. Just sharing my thoughts.*